Immunoblotting analysis suggested a trend toward reducing both di- and tri-methylation of histone H4K20 in ICM patients, compared to healthy donors, but it did not reach statistical significance ( Figure 5D-G ).
← all excerpts
Expression profiles of histone H4K20 methylation and its associated enzymes in mouse cardiac disease and human heart failure.
1
—
—